Zepto Life Technology today announced that its clinical laboratory has received accreditation from the College of American Pathologists (CAP), effective November 14, 2026.
CAP accreditation is widely recognized as the benchmark for laboratory quality, reflecting rigorous standards across testing operations, personnel, equipment, facilities, safety and quality systems.
“Behind every specimen is a patient waiting for answers,” said Hannah Zhang, Chief Executive Officer of Zepto Life Technology. “The quality of our work matters to that patient and the clinicians caring for them. CAP accreditation recognizes the standards our laboratory team works hard to uphold every day.”
Read the article: Zepto Life Technology Earns CAP Accreditation